160 related articles for article (PubMed ID: 35368707)
1. Familial Hypercholesterolemia: Real-World Data of 1236 Patients Attending a Czech Lipid Clinic. A Retrospective Analysis of Experience in More than 50 years. Part II. Clinical Characteristics.
Altschmiedova T; Todorovova V; Vrablik M; Ceska R
Front Genet; 2022; 13():849267. PubMed ID: 35368707
[No Abstract] [Full Text] [Related]
2. Familial Hypercholesterolemia: Real-World Data of 1236 Patients Attending a Czech Lipid Clinic. A Retrospective Analysis of Experience in More than 50 years. Part I: Genetics and Biochemical Parameters.
Todorovova V; Altschmiedova T; Vrablik M; Ceska R
Front Genet; 2022; 13():849008. PubMed ID: 35295947
[No Abstract] [Full Text] [Related]
3. Equivalent Impact of Elevated Lipoprotein(a) and Familial Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease.
Hedegaard BS; Bork CS; Kaltoft M; Klausen IC; Schmidt EB; Kamstrup PR; Langsted A; Nordestgaard BG
J Am Coll Cardiol; 2022 Nov; 80(21):1998-2010. PubMed ID: 36396201
[TBL] [Abstract][Full Text] [Related]
4. In pediatric familial hypercholesterolemia, lipoprotein(a) is more predictive than LDL-C for early onset of cardiovascular disease in family members.
Zawacki AW; Dodge A; Woo KM; Ralphe JC; Peterson AL
J Clin Lipidol; 2018; 12(6):1445-1451. PubMed ID: 30150142
[TBL] [Abstract][Full Text] [Related]
5. Search for familial hypercholesterolemia patients in an Italian community: A real-life retrospective study.
Fasano T; Trenti C; Negri EA; Guiducci V; Foracchia M; Bonelli E; Canovi S; Besutti G; Bertolini S; Calandra S
Nutr Metab Cardiovasc Dis; 2022 Mar; 32(3):577-585. PubMed ID: 35123858
[TBL] [Abstract][Full Text] [Related]
6. Low-density lipoprotein apheresis: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2007; 7(5):1-101. PubMed ID: 23074505
[TBL] [Abstract][Full Text] [Related]
7. Use of Lipoprotein(a) to improve diagnosis and management in clinical familial hypercholesterolemia.
Tromp TR; Ibrahim S; Nurmohamed NS; Peter J; Zuurbier L; Defesche JC; Reeskamp LF; Hovingh GK; Stroes ESG
Atherosclerosis; 2023 Jan; 365():27-33. PubMed ID: 36473758
[TBL] [Abstract][Full Text] [Related]
8. Sex-related differences in premature cardiovascular disease in familial hypercholesterolemia.
Agarwala A; Deych E; Jones LK; Sturm AC; Aspry K; Ahmad Z; Ballantyne CM; Goldberg AC
J Clin Lipidol; 2023; 17(1):150-156. PubMed ID: 36470719
[TBL] [Abstract][Full Text] [Related]
9. Long term follow-up of genetically confirmed patients with familial hypercholesterolemia treated with first and second-generation statins and then with PCSK9 monoclonal antibodies.
Pasta A; Cremonini AL; Formisano E; Fresa R; Bertolini S; Pisciotta L
Atherosclerosis; 2020 Sep; 308():6-14. PubMed ID: 32771803
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein(a): A Concealed Precursor of Increased Cardiovascular Risk? A Real-World Regional Lipid Clinic Experience.
Anastasiou G; Sakka E; Blathra E; Kalivi A; Elisaf M; Liamis G; Liberopoulos E
Arch Med Res; 2021 May; 52(4):397-404. PubMed ID: 33380360
[TBL] [Abstract][Full Text] [Related]
11. Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study).
Pérez de Isla L; Alonso R; Mata N; Saltijeral A; Muñiz O; Rubio-Marin P; Diaz-Diaz JL; Fuentes F; de Andrés R; Zambón D; Galiana J; Piedecausa M; Aguado R; Mosquera D; Vidal JI; Ruiz E; Manjón L; Mauri M; Padró T; Miramontes JP; Mata P;
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):2004-10. PubMed ID: 27444203
[TBL] [Abstract][Full Text] [Related]
12. Prediction of Familial Hypercholesterolemia in Patients at High Atherosclerotic Cardiovascular Disease Risk Using a Recently Validated Algorithm.
Alothman L; Zawadka M; Aljenedil S; Kajil M; Bewick D; Gaudet D; Hegele RA; Lonn E; Ngui D; Ruel I; Tsigoulis M; Singh N; Genest J; Gupta M
CJC Open; 2019 Jul; 1(4):190-197. PubMed ID: 32159106
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein-associated phospholipase A₂ activity is increased in patients with definite familial hypercholesterolemia compared with other forms of hypercholesterolemia.
Mattina A; Rosenbaum D; Bittar R; Bonnefont-Rousselot D; Noto D; Averna M; Bruckert E; Giral P
Nutr Metab Cardiovasc Dis; 2018 May; 28(5):517-523. PubMed ID: 29525223
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal low density lipoprotein cholesterol goal achievement and cardiovascular outcomes among adult patients with familial hypercholesterolemia: The CASCADE FH registry.
Duell PB; Gidding SS; Andersen RL; Knickelbine T; Anderson L; Gianos E; Shrader P; Kindt I; O'Brien EC; McCann D; Hemphill LC; Ahmed CD; Martin SS; Larry JA; Ahmad ZS; Kullo IJ; Underberg JA; Guyton J; Thompson P; Wilemon K; Roe MT; Rader DJ; Cuchel M; Linton MF; Shapiro MD; Moriarty PM; Knowles JW
Atherosclerosis; 2019 Oct; 289():85-93. PubMed ID: 31487564
[TBL] [Abstract][Full Text] [Related]
15. Familial Hypercholesterolemia Identification Algorithm in Patients with Acute Cardiovascular Events in A Large Hospital Electronic Database in Bulgaria: A Call for Implementation.
Petrov I; Postadzhiyan A; Vasilev D; Kasabov R; Tokmakova M; Nikolov F; Istatkov V; Zhao B; Mutafchiev D; Petkova R
Adv Ther; 2021 May; 38(5):2323-2338. PubMed ID: 33754300
[TBL] [Abstract][Full Text] [Related]
16. Elevated Lipoprotein(a) Level Influences Familial Hypercholesterolemia Diagnosis.
Chubykina UV; Ezhov MV; Afanasieva OI; Klesareva EA; Pokrovsky SN
Diseases; 2022 Jan; 10(1):. PubMed ID: 35225859
[TBL] [Abstract][Full Text] [Related]
17. Polygenic Contribution to Low-Density Lipoprotein Cholesterol Levels and Cardiovascular Risk in Monogenic Familial Hypercholesterolemia.
Trinder M; Paquette M; Cermakova L; Ban MR; Hegele RA; Baass A; Brunham LR
Circ Genom Precis Med; 2020 Oct; 13(5):515-523. PubMed ID: 33079599
[TBL] [Abstract][Full Text] [Related]
18. Familial Hypercholesterolemia-Risk-Score: A New Score Predicting Cardiovascular Events and Cardiovascular Mortality in Familial Hypercholesterolemia.
Paquette M; Bernard S; Cariou B; Hegele RA; Genest J; Trinder M; Brunham LR; Béliard S; Baass A
Arterioscler Thromb Vasc Biol; 2021 Oct; 41(10):2632-2640. PubMed ID: 34433300
[TBL] [Abstract][Full Text] [Related]
19. Association between lipoprotein(a) concentrations and atherosclerotic cardiovascular disease risk in patients with familial hypercholesterolemia: an analysis from the HELLAS-FH.
Anagnostis P; Rizos CV; Skoumas I; Rallidis L; Tziomalos K; Skalidis E; Kotsis V; Doumas M; Kolovou G; Sfikas G; Garoufi A; Lambadiari V; Dima I; Kiouri E; Agapakis D; Zacharis E; Antza C; Kolovou V; Koumaras C; Bantouvakis G; Liamis G; Liberopoulos EN
Endocrine; 2022 May; 76(2):324-330. PubMed ID: 35262845
[TBL] [Abstract][Full Text] [Related]
20. Familial hypercholesterolemia and cardiovascular disease in older individuals.
Coutinho ER; Miname MH; Rocha VZ; Bittencourt MS; Jannes CE; Tada MT; Lima IR; Filho WS; Chacra AP; Pereira AC; Krieger JE; Santos RD
Atherosclerosis; 2021 Feb; 318():32-37. PubMed ID: 33450476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
